
BOLD
Healthcare · Biotechnology · $59.0M market cap
$2.51+0.05 (+2.0%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +12.5% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | Before the open | — | -0.23 | — |
| Aug 7, 2026 | Time not confirmed | -0.58 | -1.06 | -82.8% |
| May 8, 2026 | Before the open | -0.51 | -0.60 | -17.6% |
| Mar 26, 2026 | Time not confirmed | -1.16 | -0.58 | +50.0% |
| Nov 5, 2025 | Before the open | -0.53 | -0.62 | -17.0% |
| Aug 5, 2025 | Before the open | -0.65 | -0.70 | -7.7% |
| May 9, 2025 | Before the open | -0.73 | -0.71 | +2.7% |
| Mar 27, 2025 | Time not confirmed | -0.84 | -0.74 | +11.9% |
| Nov 7, 2024 | After the close | -0.74 | -0.74 | 0.0% |
| Aug 12, 2024 | After the close | -0.81 | -0.77 | +4.9% |
| May 13, 2024 | Before the open | -0.45 | -12.27 | -2626.7% |
| Feb 28, 2024 | Time not confirmed | — | -9.76 | — |
| Nov 7, 2019 | After the close | -1.07 | -1.00 |
Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer,…
| +6.5% |
| Aug 6, 2019 | After the close | -1.04 | -1.01 | +2.9% |
| May 7, 2019 | After the close | -0.89 | -1.13 | -27.0% |
| Feb 27, 2019 | After the close | -0.91 | -0.84 | +7.7% |
| Nov 6, 2018 | After the close | -0.88 | -0.97 | -10.2% |
| Aug 7, 2018 | Before the open | -0.78 | -0.85 | -9.0% |
| May 9, 2018 | After the close | -0.80 | -0.74 | +7.5% |
| Mar 8, 2018 | After the close | -0.90 | -0.82 | +8.9% |